204 related articles for article (PubMed ID: 17525589)
1. Long-term effects of botulinum toxin on neuromuscular function.
Frick CG; Richtsfeld M; Sahani ND; Kaneki M; Blobner M; Martyn JA
Anesthesiology; 2007 Jun; 106(6):1139-46. PubMed ID: 17525589
[TBL] [Abstract][Full Text] [Related]
2. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.
Frick CG; Fink H; Blobner M; Martyn J
Anesth Analg; 2012 Jan; 114(1):102-9. PubMed ID: 22003222
[TBL] [Abstract][Full Text] [Related]
3. Train-of-four and tetanic fade are not always a prejunctional phenomenon as evaluated by toxins having highly specific pre- and postjunctional actions.
Nagashima M; Yasuhara S; Martyn JAJ
Anesth Analg; 2013 May; 116(5):994-1000. PubMed ID: 23477960
[TBL] [Abstract][Full Text] [Related]
4. Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
Frick CG; Helming M; Martyn JA; Blobner M; Fink H
Crit Care Med; 2010 Mar; 38(3):922-7. PubMed ID: 20009758
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of atracurium-induced tetanic fade in the isolated rat muscle.
Nascimento DC; Serra CS; Oliveira AC
Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):9-14. PubMed ID: 15245570
[TBL] [Abstract][Full Text] [Related]
6. Tetanic fade following atracurium-induced neuromuscular blockade in the rat diaphragm preparation.
Wali FA; Suer AH; Dark CH; Tugwell AC
Acta Anaesthesiol Belg; 1989; 40(1):29-34. PubMed ID: 2728832
[TBL] [Abstract][Full Text] [Related]
7. Effect of atracurium on twitch, tetanic and post-tetanic twitch responses at the rat neuromuscular junction.
Wali FA; Suer AH
Eur J Anaesthesiol; 1987 Jan; 4(1):45-53. PubMed ID: 3034612
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors.
Fink H; Luppa P; Mayer B; Rosenbrock H; Metzger J; Martyn JA; Blobner M
Anesthesiology; 2003 Jan; 98(1):82-8. PubMed ID: 12502983
[TBL] [Abstract][Full Text] [Related]
9. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade.
Jonsson M; Gurley D; Dabrowski M; Larsson O; Johnson EC; Eriksson LI
Anesthesiology; 2006 Sep; 105(3):521-33. PubMed ID: 16931985
[TBL] [Abstract][Full Text] [Related]
10. Tetanic fade following administration of nondepolarizing neuromuscular blocking drugs.
Gibson FM; Mirakhur RK
Anesth Analg; 1989 Jun; 68(6):759-62. PubMed ID: 2567584
[TBL] [Abstract][Full Text] [Related]
11. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole potentiates atracurium and succinylcholine paralysis in vivo in rats.
Fu C; Mishra Y; Ramzan I
Anesth Analg; 1994 Mar; 78(3):527-30. PubMed ID: 8109772
[TBL] [Abstract][Full Text] [Related]
13. Treadmill running upregulates the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A injection.
Tsai SW; Tung YT; Chen HL; Shen CJ; Chuang CH; Tang TY; Chen CM
J Orthop Res; 2013 Jan; 31(1):125-31. PubMed ID: 22733692
[TBL] [Abstract][Full Text] [Related]
14. Assessment of neuromuscular blockade produced by atracurium in the rat diaphragm preparation. Measurements of tetanic fade, depression and recovery profile.
Wali FA; Suer AH; Dark CH; Tugwell AC
Pharmacol Res; 1989; 21(2):231-8. PubMed ID: 2748509
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity.
Bornia EC; Correia-de-Sá P; Alves-Do-Prado W
Clin Exp Pharmacol Physiol; 2011 Mar; 38(3):164-9. PubMed ID: 21208254
[TBL] [Abstract][Full Text] [Related]
16. Block of postjunctional muscle-type acetylcholine receptors in vivo causes train-of-four fade in mice.
Nagashima M; Sasakawa T; Schaller SJ; Martyn JA
Br J Anaesth; 2015 Jul; 115(1):122-7. PubMed ID: 25835024
[TBL] [Abstract][Full Text] [Related]
17. Prednisolone-induced muscle dysfunction is caused more by atrophy than by altered acetylcholine receptor expression.
Shin YS; Fink H; Khiroya R; Ibebunjo C; Martyn J
Anesth Analg; 2000 Aug; 91(2):322-8. PubMed ID: 10910842
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by cimetidine of neuromuscular paralysis induced with atracurium in rats.
Mishra Y; Ramzan I
Arch Int Pharmacodyn Ther; 1992; 318():97-106. PubMed ID: 1463374
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular blocking drug pharmacodynamics after chronic exposure to H2- antagonists.
Rana J; Ramzan I
In Vivo; 1995; 9(2):163-6. PubMed ID: 7548793
[TBL] [Abstract][Full Text] [Related]
20. Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine.
Spacek A; Neiger FX; Spiss CK; Kress HG
Acta Anaesthesiol Scand; 1997 Nov; 41(10):1308-11. PubMed ID: 9422297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
